{
    "nct_id": "NCT05142267",
    "official_title": "Stress and Opioid Misuse Risk: The Role of Endogenous Opioid and Endocannabinoid Mechanisms",
    "inclusion_criteria": "* Intact cognitive status and ability to provide informed consent\n* Ability to read and write in English sufficiently to understand and complete study questionnaires (which are only validated in English)\n* Age 18 or older And\n* Presence of persistent daily low back pain of at least three months duration and of at least a 3/10 in average intensity\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* History of renal or hepatic dysfunction\n* Reports of current or past alcohol or substance abuse or treatment for such condition\n* A reported history of PTSD, psychotic, or bipolar disorders\n* Chronic pain due to malignancy (e.g., cancer) or autoimmune disorders (e.g., rheumatoid arthritis, lupus)\n* Reports of recent benzodiazepine use (confirmed via rapid urine screening prior to each lab session)\n* Any medical conditions (e.g., significant cardiovascular disease) that the study physician feels would contraindicate participation in the lab stressors\n* Reported daily opiate use within the past 6 months, or use of any opioid analgesic medications within 3 days of study participation (confirmed through rapid urine screening prior to each lab session)\n* Pregnancy (females only, to avoid fetal drug exposure - pregnancy tests conducted prior to each lab session to confirm eligibility)\n* Prior allergic reaction/intolerance to oxycodone or its analogs",
    "miscellaneous_criteria": ""
}